Cargando…

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles

Long-acting parenteral (LAP) antiretroviral drugs have generated considerable interest for treatment and prevention of HIV-1 infection. One new LAP is cabotegravir (CAB), a highly potent integrase inhibitor, with a half-life of up to 54 days, allowing for every other month parenteral administrations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tian, Su, Hang, Dash, Prasanta, Lin, Zhiyi, Shetty, Bhagya Laxmi Dyavar, Kocher, Ted, Szlachetka, Adam, Lamberty, Benjamin, Fox, Howard S., Poluektova, Larisa, Gorantla, Santhi, McMillan, JoEllyn, Gautam, Nagsen, Mosley, R. Lee, Alnouti, Yazen, Edagwa, Benson, Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926202/ https://www.ncbi.nlm.nih.gov/pubmed/29059541 http://dx.doi.org/10.1016/j.biomaterials.2017.10.023

Ejemplares similares

A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
por: Kulkarni, Tanmay A., et al.
Publicado: (2020)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021)

Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne, Georgette D, et al.
Publicado: (2012)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022)

Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015)

Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
por: Montenegro-Burke, J. Rafael, et al.
Publicado: (2018)

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
por: Epstein, Adrian A., et al.
Publicado: (2013)

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
por: Balkundi, Shantanu, et al.
Publicado: (2010)

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015)

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi, Shantanu, et al.
Publicado: (2011)

Humanized Mice for Studies of HIV-1 Persistence and Elimination
por: Zhang, Chen, et al.
Publicado: (2023)

Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains
por: Li, Weizhe, et al.
Publicado: (2017)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection
por: Dash, Prasanta K., et al.
Publicado: (2021)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021)

Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice
por: Su, Hang, et al.
Publicado: (2020)

HIV-1 cellular and tissue replication patterns in infected humanized mice
por: Araínga, Mariluz, et al.
Publicado: (2016)

Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice
por: Su, Hang, et al.
Publicado: (2019)

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2019)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice
por: McMillan, JoEllyn M., et al.
Publicado: (2018)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2020)

Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice
por: Su, Hang, et al.
Publicado: (2021)

Animal models for studies of HIV‐1 brain reservoirs
por: Waight, Emiko, et al.
Publicado: (2022)

Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy
por: Li, Tianyuzi, et al.
Publicado: (2015)

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
por: Dash, Prasanta K., et al.
Publicado: (2023)

Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nlpumlrkj6ofjnaoeot8po7l52